Revolution Medicines Revenue vs. Total Debt
| RVMD Stock | USD 57.50 0.75 1.32% |
Total Revenue | First Reported 2018-09-30 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 4.9 M |
For Revolution Medicines profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Revolution Medicines to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Revolution Medicines utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Revolution Medicines's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Revolution Medicines over time as well as its relative position and ranking within its peers.
Revolution |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revolution Medicines. If investors know Revolution will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revolution Medicines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.71) | Revenue Per Share 0.005 | Quarterly Revenue Growth (0.95) | Return On Assets (0.29) | Return On Equity (0.47) |
The market value of Revolution Medicines is measured differently than its book value, which is the value of Revolution that is recorded on the company's balance sheet. Investors also form their own opinion of Revolution Medicines' value that differs from its market value or its book value, called intrinsic value, which is Revolution Medicines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revolution Medicines' market value can be influenced by many factors that don't directly affect Revolution Medicines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revolution Medicines' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revolution Medicines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revolution Medicines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Revolution Medicines Total Debt vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Revolution Medicines's current stock value. Our valuation model uses many indicators to compare Revolution Medicines value to that of its competitors to determine the firm's financial worth. Revolution Medicines is rated third in revenue category among its peers. It is rated second in total debt category among its peers making up about 7.59 of Total Debt per Revenue. At present, Revolution Medicines' Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Revolution Medicines by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Revolution Revenue vs. Competition
Revolution Medicines is rated third in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 157.39 Million. Revolution Medicines holds roughly 11.58 Million in revenue claiming about 7% of equities under Health Care industry.
Revolution Total Debt vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revolution Medicines |
| = | 11.58 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Revolution Medicines |
| = | 87.94 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Revolution Total Debt vs Competition
Revolution Medicines is rated second in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 401.16 Million. Revolution Medicines totals roughly 87.94 Million in total debt claiming about 22% of equities under Health Care industry.
Revolution Medicines Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Revolution Medicines, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Revolution Medicines will eventually generate negative long term returns. The profitability progress is the general direction of Revolution Medicines' change in net profit over the period of time. It can combine multiple indicators of Revolution Medicines, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 544 K | 571.2 K | |
| Net Interest Income | 47.2 M | 49.5 M | |
| Interest Income | 47.5 M | 49.9 M | |
| Operating Income | -487.2 M | -462.8 M | |
| Net Loss | -436.4 M | -414.5 M | |
| Income Before Tax | -439.9 M | -417.9 M | |
| Total Other Income Expense Net | 47.3 M | 49.7 M | |
| Net Loss | -223.8 M | -212.6 M | |
| Net Loss | -436.4 M | -414.5 M | |
| Income Tax Expense | -3.5 M | -3.7 M | |
| Non Operating Income Net Other | 836.1 K | 1.3 M | |
| Change To Netincome | 32.4 M | 34 M | |
| Net Loss | (3.86) | (4.05) | |
| Income Quality | 0.80 | 0.60 | |
| Net Income Per E B T | 0.99 | 0.78 |
Revolution Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Revolution Medicines. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Revolution Medicines position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Revolution Medicines' important profitability drivers and their relationship over time.
Use Revolution Medicines in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Revolution Medicines position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will appreciate offsetting losses from the drop in the long position's value.Revolution Medicines Pair Trading
Revolution Medicines Pair Trading Analysis
The ability to find closely correlated positions to Revolution Medicines could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Revolution Medicines when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Revolution Medicines - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Revolution Medicines to buy it.
The correlation of Revolution Medicines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Revolution Medicines moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Revolution Medicines moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Revolution Medicines can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Revolution Medicines position
In addition to having Revolution Medicines in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Software Thematic Idea Now
Software
Companies that develop and distribute software and software systems to individuals or business. The Software theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Software Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For information on how to trade Revolution Stock refer to our How to Trade Revolution Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
To fully project Revolution Medicines' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Revolution Medicines at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Revolution Medicines' income statement, its balance sheet, and the statement of cash flows.